Bronchitis: Clinical Trials

125 trials for Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

125 completed. 125 Phase 3, 15 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3125Completed 125
Phase 215Completed 15

Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis

Trials (filtered) newest first · largest first

All 125 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
YHP2401, YHR2402, YHR2403 - Acute Bronchitis
Phase 3CompletedYuhan Corporation2862025-08-192026-02-09
Hyaluronic Acid Mouthwash as Adjunct
Hyaluoric acid mouthwash, Chlorhexidine 0,12% - Gingivitis; Chronic
Phase 3CompletedCairo University162025-02-012026-01-26
A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212
DW5121, DW51211, DW51212 - Acute Bronchitis
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.2732024-03-282025-07-30
Efficacy of Vitamin D Supplementation for Children With Bronchiolitis
Vitamin D3 - Bronchiolitis
Phase 2 / Phase 3CompletedSohag University1462023-04-012024-10-29
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
3% Sodium Chloride, Standard care - Acute Bronchiolitis
Phase 2 / Phase 3CompletedCan Tho University of Medicine and Pharmacy1402022-06-012024-08-16
Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial
Roflumilast, Azithromycin - Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis
Phase 3CompletedJohns Hopkins University10322020-02-112026-08-21
Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2
Nintedanib, Placebo - Lung-transplant Recipients
Phase 3CompletedAssistance Publique - Hôpitaux de Paris582019-10-302025-09-08
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
AGS (Experimental), AGU (Active Comparator) - Acute Bronchitis
Phase 3CompletedAhn-Gook Pharmaceuticals Co.,Ltd2202019-10-172022-04-25
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Erenumab, Placebo - Migraine
Phase 3CompletedNovartis Pharmaceuticals5572019-08-262025-10-16
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
N-acetylcysteine (NAC) 600 mg, Ambroxol hydrochloride 30 mg, placebo - Respiratory Tract Diseases, Abnormal Mucus Secretions
Phase 3CompletedZambon SpA3332019-06-252025-09-05
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Liposomal Cyclosporine A, standard of care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA622019-03-262025-10-27
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Liposomal Cyclosporine A, Standard of Care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant
Phase 3CompletedZambon SpA1692019-03-262026-02-10
Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone Study
Oral dexamethasone, Nebulized Epinephrine, Oral placebo - Bronchiolitis
Phase 3CompletedChildren's Hospital of Eastern Ontario8642018-12-132025-07-28
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients
HL301(Experimental), Umkamin(Active Comparator) - Acute Bronchitis
Phase 3CompletedHanlim Pharm. Co., Ltd.2462018-03-162019-02-12
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Tx360 - Headache, Migraine
Phase 3CompletedTian Medical Inc.1742017-09-202024-01-05
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Ruxolitinib, Extracorporeal photopheresis (ECP), Low-dose methotrexate (MTX) - Graft-versus-host Disease (GVHD)
Phase 3CompletedIncyte Corporation3302017-06-292025-08-12
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
ibrutinib, Placebo, Prednisone - Chronic Graft Versus Host Disease
Phase 3CompletedPharmacyclics LLC.1932017-05-112023-03-30
Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Nitric Oxide, Supportive treatment - Bronchiolitis
Phase 3CompletedBeyond Air Inc.692017-03-052019-07-09
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Glecaprevir/Pibrentasvir - Hepatitis C Virus (HCV)
Phase 3CompletedAbbVie842017-01-252021-07-30
Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Levotuss - Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Phase 3CompletedHyundai Pharm2722017-01-012018-11-20

Showing 20 of 125. Sign in to see all of them.

Narrower conditions

Bronchiolitis Obliterans Syndrome (55)  ·  Bronchitis, Chronic (27)  ·  Bronchiolitis (24)  ·  Pulmonary Disease, Chronic Obstructive (24)  ·  Emphysema (15)  ·  Bronchiolitis Obliterans (7)  ·  Leukemia (6)  ·  Lymphoma, Follicular (6)  ·  Psoriasis (6)  ·  Respiratory Tract Infections (6)  ·  Cough (5)  ·  Migraine Disorders (5)  ·  Pruritus (5)  ·  Constipation (4)

Broader conditions

Lung Diseases, Obstructive (123)  ·  Bronchial Diseases (122)  ·  Lung Diseases (122)  ·  Respiratory Tract Diseases (122)  ·  Infections (76)  ·  Pathological Conditions, Signs and Symptoms (73)  ·  Bronchiolitis (61)  ·  Respiratory Tract Infections (60)  ·  Immune System Diseases (57)  ·  Organizing Pneumonia (55)  ·  Bronchiolitis Obliterans (54)  ·  Graft vs Host Disease (53)  ·  Pathologic Processes (44)  ·  Chronic Disease (42)

Interventions

aclidinium bromide (9)  ·  Formoterol Fumarate (7)  ·  Azithromycin (6)  ·  Saline Solution (6)  ·  Sodium Chloride (6)  ·  tofacitinib (6)  ·  Imatinib Mesylate (5)  ·  Levofloxacin (4)  ·  Salmeterol Xinafoate (4)  ·  Standard of Care (4)  ·  Amoxicillin (3)  ·  Fluticasone (3)  ·  Saline Solution, Hypertonic (3)  ·  Tacrolimus (3)  ·  Topiramate (3)

Sponsors

Pfizer (11)  ·  AstraZeneca (9)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6)  ·  Novartis Pharmaceuticals (6)  ·  Ahn-Gook Pharmaceuticals Co.,Ltd (4)  ·  Baqiyatallah Medical Sciences University (4)  ·  GlaxoSmithKline (4)  ·  Sumitomo Pharma America, Inc. (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Gilead Sciences (3)  ·  Zambon SpA (3)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (2)  ·  McMaster University (2)  ·  Mundipharma Research GmbH & Co KG (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)

Countries

United States (42)  ·  Canada (28)  ·  Germany (24)  ·  France (21)  ·  Spain (19)  ·  United Kingdom (18)  ·  South Korea (17)  ·  Australia (14)  ·  Belgium (14)  ·  Poland (13)  ·  Italy (11)  ·  Netherlands (11)  ·  Hungary (10)  ·  Israel (10)  ·  Austria (9)

Top investigators

Esther Garcia, MD (7)  ·  Mary Horowitz, MD (2)  ·  Mostafa Ghanei, MD (2)  ·  Paola Castellani, MD (2)  ·  Alan Jackson, MB, BS (1)  ·  Allan Glanville, MD, PhD (1)  ·  Alun George, MA MBBS, DRCOG, DCH, MRCGP (1)

Results publications

PMID 32816215, PMID 26149717, PMID 26233481, PMID 28396102, PMID 28558833, PMID 31827323, PMID 12563043, PMID 15121942, PMID 16352625, PMID 17261234, PMID 17300356, PMID 18668692, PMID 19860762, PMID 20109213, PMID 20347286, PMID 21183326, PMID 21943218, PMID 22147778, PMID 22230731, PMID 22320148, PMID 22645182, PMID 23380743, PMID 23668548, PMID 23679347, PMID 24085591, PMID 24139233, PMID 24229360, PMID 24268590, PMID 24382580, PMID 24410959, PMID 24521787, PMID 24862623, PMID 24881631, PMID 24928639, PMID 25038354, PMID 25404569, PMID 25418186, PMID 25583164, PMID 25756831, PMID 25788164, PMID 26051365, PMID 26182309, PMID 26278222, PMID 26286532, PMID 26743093, PMID 26784000, PMID 26871197, PMID 27215749, PMID 27271195, PMID 27296819

NIH funding

2018 (3), 2014 (2), 2015 (2), 2016 (2), U01HL069294 (2), 2008 (1), R01HL053755 (1), U01AT001908 (1), U01IP000127 (1), U24CA076518 (1)